Bavarian Nordic expects imminent European monkeypox green light
Experts agreed Friday to recommend adding monkeypox to the label of the Danish biotech firm’s vaccine, meaning official EU approval could be right around the corner, says a Bavarian representative.
.jpg)
by marketwire, translated by daniel pedersen
Bavarian Nordic is counting on the imminent European authorization to expand smallpox vaccine Imvanex’s label to include monkeypox, according to Head of Investor Relations at the firm Rolf Sass Sørensen.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg)
.jpg&w=384&q=75)
